[Posterior reversible encephalopathy syndrome associated to chemotherapy. Gemcitabine as the causative agent]

Rev Neurol. 2017 Jun 16;64(12):574-575.
[Article in Spanish]

Abstract

Title: Sindrome de encefalopatia posterior reversible asociado a quimioterapia. Gemcitabina como agente causal.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects*
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Female
  • Gemcitabine
  • Humans
  • Middle Aged
  • Posterior Leukoencephalopathy Syndrome / chemically induced*

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Gemcitabine